The US president insisted both sides were 'very close' to an agreement and that Iran had conceded on nuclear weapons, but 'a couple of points' remained.
READ MOREThe North Korean leader was accompanied by his teenage daughter,believed to be named Kim Ju Ae,while inspecting a new warship (Picture: KCNA via KNS via AP)
A heated constitutional and political battle is unfolding in Senegal as lawmakers examine whether Ousmane Sonko can reclaim his parliamentary seat after leaving government. The debate could reshape the balance of power inside the National Assembly.
BEIJING,Nov. 9,2024-- A report from People\'s Daily:Yunmeng county in central China\'s Hubei province is leveraging its rich historical and cultural resources to boost the development of cultural tour
Shanghai Electric signed new memoranda of cooperation and strategic agreements with Carrier Group and Svenska Kullagerfabriken AB (SKF) China Sales Co.,Ltd. at CIIE 2024
Announcing North Asia BIG BANG Beauty Tech Innovation Program 2024 Winnersand New Sustainability Track
SYDNEY,Nov. 4,2024-- Australian-founded brokerFP Marketsfurther cemented its position as a market leader,winning \'Most Trusted Broker - Global\',\'Broker of the Year - Asia\',and \'Fastest Growing B
SHANGHAI,Nov. 4,2024--As an authorized global distributor,Mouser Electronics,Inc. is focused on the rapid65 introduction of new products and technologies,giving customers an edge and helping speed ti
HONG KONG,Nov. 4,2024-- TheZ Label,a tech-centric venture building group in Hong Kong,has raised $11.4 million led by Beyond Ventures to build up a portfolio of products for global GenZ consumers. The
CHICAGO,Nov. 4,2024-- AtFABTECH 2024 in Orlando,October 15-17,Tailift showcased its latest advancements in intelligent manufacturing,attracting extensive industry attention. Known for its technical in
Part of HSBC\'s ASEAN Growth Fund,an accumulative commitment of over US$100 million to Funding Societies since its partnership established in 2022
SHANGHAI,Nov. 5,2024-- BioCity Biopharma (BioCity) announced late-breaking results of the 2-SUCCEED clinical trial of SC0062,a selective endothelin receptor type A (ETA) antagonist,for the treatment o
International travelers can now pay like locals at more than 35 million merchants across Asia Pacific
© OfficialAffairs
